Introduction
============

Foot-and-mouth disease virus (FMDV) belongs to the *Aphthovirus* genus in the *Picornaviridae* family, and a highly infection disease caused by FMDV is regarded as an important concern for animal health ([@B45]). During FMDV evolutionary process, high mutation rates of the viral genome and quasispecies dynamics are considered major genetic factors ([@B76]). Thus, a series of studies were conducted to examine the relationship between genetic changes of the viral genome and viral fitness and different host/viral pathogenicities. Except for positive/negative selection and the random drift of the genome ([@B18]), synonymous codon usage patterns of the FMDV genome also dominate its host ranges and viral proteins with normal biological functions ([@B98],[@B99], [@B100], [@B95],[@B96],[@B97]; [@B1]; [@B58]; [@B56]; [@B26]). Due to the high genetic diversity of FMDV, the measures for controlling this disease need to be developed comprehensively, including killing infected and in-contact animals, the limitation of animal movement and vaccination based on conventional vaccines or new typical ones ([@B69]). To further improve measures involved in antiviral treatments and novel vaccines for controlling rapid FMDV spread, it is important to obtain a deep understanding of the interaction between the host and FMDV. The antiviral immune response is the major focus on resisting FMDV infection, including innate/adaptive immune activations ([@B27]; [@B80]). The innate immune system serves as the first line of defense for resisting viral infections. The rapid induction of type I interferon (IFN) and other antiviral cytokines at the site of infection are part of the defense involved in antiviral immunity. The type I IFN family of placental mammals comprises 9 recognized classes identified to date: IFN-α, IFN-β, IFN-δ, IFN-ε, IFN-κ, IFN-τ, IFN-ω, IFN-ν, and IFN-ζ ([@B46]; [@B16]).

Type I IFNs exhibit direct antiviral activities by inhibiting viral replication and mediating the cellular immune functions of both the innate and adaptive immune system, resulting in both early limitation of the virus and long-term immunity. However, viruses are capable of selecting various strategies to evade the host immune system and thus contributing to viral pathogenicity ([@B73]; [@B36]; [@B78]). For FMDV infection, type I IFNs also play important roles in counteracting viral infection represent a potent biotherapeutic method against FMDV ([@B70]; [@B7]). This minireview summarizes the current knowledge on how type I IFN is resistant to FMDV infection and how FMDV counteracts type I IFN induction and signaling transduction to evade the type I IFN system of host.

Recognition of Viral Genome for IFN Production
==============================================

Once viral infection occurs, cells of the infected host can trigger a series of activations of cytokines, including type I and type III IFNs. These IFNs can perform multiple biological functions related to antiviral, antiproliferative and immunomodulatory activations and trigger various interferon stimulated genes (ISGs), thereby contributing to the establishment of the antiviral state in which various steps of viral replication are restricted ([@B74]; [@B24]). Notably, both type I and type III IFNs represent similar patterns of expression and mechanisms of induction ([@B82]). A pivotal feature of IFN expression is the requirement for detection of the invading pathogens by pathogen-associated receptors. Generally, the innate immune system relies on germ-line-encoded pattern recognition receptors (PRRs) to recognize non-self RNA (viral RNA) which is one of the pathogen-associated molecular patterns (PAMPs) ([@B2]). For recognizing the viral RNA genome by the PRRs, there are two major classes of PRRs: Toll-like receptor (TLRs) at the cell surface or in endosomes, and retinoic acid-inducible gene-I (RIG-I) like receptors (RLRs) ([@B2]; [@B9]). Among TLRs related to antiviral immune response, TLR 3 can recognize double-stranded RNA (ds RNA) and TLRs 7/8 can recognize single-stranded RNA ([@B3]; [@B17]; [@B31]). However, TLR3 can sense ssRNA of poliovirus in some conditions ([@B79]). Turning to RIG-I like receptor, which is involved in the antiviral immune response (**Figure [1](#F1){ref-type="fig"}**), melanoma differentiation-associated gene 5 (MDA5), laboratory of genetics and physiology 2 (LGP2) and RIG-I, which are ubiquitous cytosolic RNA helicases, play a pivotal role in recognizing viral RNA fragments ([@B92]). It has been accepted that RIG-I can preferentially sense short dsRNAs, while MDA5 can recognize long dsRNA ([@B39]; [@B4]; [@B54]). Compared with the physical organizations and biological functions of MDA5 and RIG-I, LGP2 loses its CARD domain and displays a regulatory role that works as a concentration dependent biphasic status to mediate activations of MDA5 ([@B10], [@B9]; [@B81]). Interestingly, RIG-I deficiency does not inhibit the replication of *Picornaviridae*, while MDA5 displays a remarkable role in resisting these viruses ([@B40]). Depending on the mice model with LGP2 deletion, dendritic cells (DCs) derived from these mice fail to generate IFN production upon infection by encephalomyocarditis virus (EMCV), vesicular stomatitis virus (VSV), and Newcastle disease virus (NDV) ([@B83]; [@B72]), suggesting that LGP2 might play a positive role *in vitro* by recognize some viral infections to promote IFN production.

![Physical organization of RLs. Schematic representation of RLR domains. The caspase activation and recruitment domain (CARD), helicase domain and RNA recognition domain are shown. LGP2 lacks the N-terminal CARD domain used by MDA5 and RIG-I for signal transduction.](fmicb-09-01862-g001){#F1}

Recognition of FMDV RNA by TLRS and RLRS
========================================

The differential viral recognition by RIG-I and MDA5 is partly due to the differential recognition of distinct types of RNA patterns. It has been reported that MDA5 can recognize ssRNA involved in EMCV, Theiler's virus and Mengo virus to activate IFN systems ([@B40]). Like those (+) ssRNA viruses mentioned above, FMDV RNA was recognized by MDA5 rather than by TLR3 or RIG-I in porcine epithelial cells, based on the result of the porcine kidney (PK-15) cells with MDA5 knockdown by RNA interference ([@B35]). According to the current knowledge on the length of RNA sensed by RIG-I and MDA5 ([@B39]), the FMDV genomes longer than 8000 nt are proposed to be sensed by MDA5 but not by RIG-I. Even though FMDV breaks into target cells and inhibits host translational systems by generation of L^pro^ and 3C^pro^ to evade the innate immune response against viral infection, MDA5 can first initiate IFN-β expression regardless of impairment of host translational systems. In addition, EMCV can produce high molecular weight RNA with a single- and double-stranded structure, and this RNA structure is capable of triggering MDA5 ([@B67]). Notably, similar RNA structure exists in the 5′untranslation region of the FMDV genome ([@B12]), hence contributing to the activation of MDA5 to some degree. Most recently, it has been reported that the S fragment in the 5′untranslation region (UTR) of the FMDV genome is required for the replication and modulation of the innate immune response in host cells ([@B44]). In human HEK 293 cell line, the S fragment and internal ribosomal entry site of 5′UTR and 3′UTR in the FMDV genome can trigger IFN-β promoter activation ([@B8]). IFN-α/β can trigger double-stranded RNA-dependent protein kinase R (PKR) in the direct inhibition of FMDV replication *in vitro* ([@B13]; [@B14]). Turning to FMDV infection recognized by TLRs, the expression of TLR-4 in nasal-associated lymphoid tissue (NALT) during the acute stage of FMDV infection is higher than that of uninfected cattle, but non-infected and infected cattle do not differ regarding the transcription levels between TLR3 and TLR4 in NALT ([@B93]). In addition, the FMDV genome can be recognized by TLR7 and TLR9 in plasmacytoid dendritic cells (pDCs) ([@B30]; [@B47]).

FMDV-Induced Signaling Cascade and IFN Gene Activation
======================================================

After RIG-I or MDA5 bind to viral RNA, the tandem CARDs are unmasked and interact with MAVS (also termed as Cardif, IPS-1 or VISA), which contains one CARD, by CARD-CARD interaction ([@B41]; [@B62]; [@B75]; [@B90]). MAVS are located on the outer membrane of the mitochondria and this specific localization is pivotal for signal transduction, because the formation of the RLR-MAVS complex contributes to the recruitment of numerous signaling adaptors ([@B75]). Recently, Sun Hur and her colleagues have postulated a novel mechanism showing that two CARD tetramer formation is essential for triggering the MAVS prion-like structure, leading to type I interferon production ([@B89]). Notably, the Atg5-Atg12 conjugate, an essential regulator of the autophagic machinery, directly associates with the CARD of the RIG-I and IFN-β promoter (also called IPS-1 or MAVS) and further impair the interaction between RIG-I and MAVS, hence contributing to RNA virus replication in host cells ([@B37]). Interestingly, FMDV 3C^pro^ can degrade the Atg5-Atg12 complex to suppress autophagy and antiviral responses mediated by the NF-κB pathway ([@B22]). However, it needs to be noted that FMDV L^pro^ can degrade NF-κB as well and decrease IRF3/7 expression to suppress dsRNA-induced type I IFN production, thereby impairing the expression of IFNs ([@B88], [@B87]). Taken together, FMDV can adopt multiple measures to go against the antiviral immune response. IFNs are induced through transcriptional mechanisms involving the transcription factors nuclear factor (NF)-κB and the IFN regulatory factors (IRFs). The RLR-MAVS complex can recruit TRAF (tumor necrosis factor receptor-associated factor) family members and transmit signals to downstream protein kinases (inhibitor of NF-κB (IκB) kinase (IKK) family members, which are pivotal for activating the transcription factors IRF-3, IRF-7, and NF-κB ([@B38]; [@B90]), thereby contributing to IFNs expression. As an ovarian tumor domain (OUT)-containing enzyme, de-ubiquitinating enzyme (DUB) A interacts directly with TRAF3 and catalyzes the cleavage of Lys-63-linked ubiquitin chains of TRAF3, thereby contributing to the dissociation of TBK1 from TRAF3 and blocking signal transductions mediated by RLRs ([@B42]). During FMDV evolution, viral L^pro^ evolved a specific function domain which is similar to the cellular DUBs and possesses DUB activity to impair signal transduction related to type I IFN production ([@B85]). The canonical IKK complex, which is composed of IKK-α, IKK-β and the regulatory subunit NF-κB essential modulator (NEMO, or called IKK-γ), phosphorylates IκB, and subsequent proteasome-dependent degradation of IκB results in functional NF-κB moving into the nucleus ([@B38]). In contrast, non-canonical IKKs, TRAF family associated NF-κB activator (TANK)-binding kinase 1 (TBK1), and IKK-iii, activate the signal-dependent phosphorylation of IRF-3 and IRF-7 ([@B25]; [@B32]; [@B60]; [@B66]). Interaction between MAVS and TRAF3 is pivotal for the recruitment of both IKK complexes, while TRAF2 and TRAF6 are likely to be responsible for NF-κB activation ([@B90]; [@B43]). As a regulatory component, TANK and NAK-associated protein 1 (NAP1) are commonly involved in the TBK-1/IKK- iii-mediated activation of IRFs ([@B71]; [@B29]). IKK-γ (NEMO) serves as a regulatory subunit for the canonical IKK complex, which plays a role in the TBK-1/IKK- iii-mediated activation of IRFs ([@B94]). However, FMDV 3C^pro^ can also target IKK-γ at the Gln383 residue and cleave off the C-terminal Zinc finger domain from IKK-γ, thereby disrupting the RIG-I/MDA5 pathway and contributing to the inhibition of IFN production ([@B87]). Most recently, crosstalk between the canonical IKK complex and non-canonical IKK complex exists in RLR-mediated signal transduction to a perform antiviral response ([@B23]). Collectively, these studies might imply that the immune systems have evolved a comprehensive network where various cytokines and signal molecules can perform cross-talk among different signal pathways to counteract the evasion of antiviral immune responses induced by viruses.

Evasion of Antiviral Response of Type I IFN Mediated by FMDV
============================================================

Upon viral infection, innate immune responses serving as the first line of defense against viruses can induce signal transduction involving IFN and finally the expression of type I IFN, which then contributes to an antiviral stage in the cells. However, many viruses have evolved strategies to evade the antiviral immune response and prevent IFN production. Picornavirus-induced host translation system shut-off has been known to result in IFNs and other cytokine suppression ([@B11]). Due to these RNA viruses being armed with some viral proteases (i.e., L^pro^, 2A^pro^, and 3C^pro^), these proteases can target different signal transduction nodes mediated by IFN ([@B68]; [@B91]; [@B64]). FMDV is no exception and has evolved to use its production to evade the antiviral immune response against FMDV (**Figure [2](#F2){ref-type="fig"}**) and maximize viral replication and dissemination. In addition to promoting the generation of viral products with biological functions, FMDV L^pro^ and 3C^pro^ plays pivotal roles in disrupting the translational system of the host. For FMDV L^pro^, this protease is associated with translocation to the nucleus and cleavage of the p65 subunit of NF-κB ([@B15]; [@B101]). Although FMDV L^pro^ can inhibit IRF3/7 to promote the interferon-stimulated response element (ISRE) ([@B84],[@B86]), IRF9 can assist type I and III IFNs to perform antiviral response against FMDV infection ([@B77]; [@B65]), implying that the host has evolved multiple immune pathways to meet with the evasion immune response induced by FMDV. Most recently, it has been reported that FMDV L^pro^ can bind to the host transcription factor ADNP (activity dependent neuroprotective protein) to suppress IFN and ISG transcription and enhance FMDV replication ([@B61]). FMDV 3C^pro^ specializes in cleaving FMDV polyprotein into viral proteins with biological functions and ruins eIF4G, eIF4A and histone H3 to block the translation system of the host ([@B21]; [@B52]). In addition to inhibition of cell protein generation by 3C^pro^, it also disrupts the transcriptional levels of ISGs, blocks the translocation of STAT1-STAT2 complex to the nucleus and suppresses the ISKE promoter ([@B20]). These biological functions of FMDV 3C^pro^ seem to ruin the IFN system against viral infection in the broad spectrum. Like the role of EMCV 3C^pro^ in impairing the interaction TANK and TRAF6-mediated NF-κB signaling ([@B34]), FMDV 3C^pro^ also cleaves TANK to block the non-canonical IKK complex signaling pathway, rather than FMDV L^pro^ only disrupting TANK binding activity. In general, protease encoded by FMDV can negatively regulate innate immune signaling by degradation of essential molecules in different pathway.

![Evasion of antiviral response of type I IFN mediated by FMDV. FMDV Lpro can cleave the p65 subunit of NF-κB and inhibit IRF3/7, which promote the interferon-stimulated response element (ISRE). FMDV 3C^pro^ blocks the translocation of STAT1-STAT2 complex to the nucleus and suppresses the ISKE promoter. Recombinant VP1 can disrupt the formation of the canonical IKK complex to block NF-κB activity. VP3 can disrupt the assembly of the Jak1/STAT1 complex and inhibit IRF3 phosphorylation and dimerization. FMDV 2B can bind to RIG-I or LGP2 to impair related signal transduction and enhance viral replication. FMDV 3A protein can disrupt the transcriptional levels involved in RIG-I, MDA5, and MAVS and block the interaction between RIG-I/MDA5 and MAVS via its N-terminal region.](fmicb-09-01862-g002){#F2}

Apart from viral proteases of FMDV, other viral proteins play roles in viral immune evasion. VP1 and VP3 serve as viral structural proteins, which are the main components of the viral capsid ([@B59]). When the *vp1* gene was over-expressed in the human HEK293 cell line, VP1 and sorcin can reduce NF-κB at the transcriptional levels and weaken type I IFN activity; in addition, recombinant VP1 can disrupt the formation of the canonical IKK complex to block NF-κB activity ([@B53]; [@B33]). When the *vp3* gene was over-expressed in the human HEK293T cell line, VP3 disrupted the assembly of the Jak1/STAT1 complex, suggesting FMDV VP3 impairs the type II IFN signaling pathway, inducing Jak1 degradation via a lysosomal pathway; Moreover, FMDV VP3 can inhibit IRF3 phosphorylation and dimerization, thereby contributing to the impairment of signal transduction involved in the type I IFN ([@B48],[@B49]).

Turning to some non-structural proteins of FMDV, the 2B protein is capable of improving membrane permeability and carrying out cellular protein secretory pathway shut-off ([@B63]). Recently, it has been reported that FMDV 2B can bind to RIG-I or LGP2 to impair related signal transduction and enhance viral replication, but the detailed mechanisms have not been established yet ([@B103], [@B102]). Enterovirus 71 2C proteins can bind to RelA (p65) and suppress IKKβ phosphorylation to disrupt the formation of the canonical IKK complex and impair NF-κB activation ([@B19]; [@B50]). Since the 2C protein of picornaviruses are highly conserved ([@B28]), it is assumed that FMDV 2C should possess most of these activities involved in immune evasion. The FMDV 3A protein is a multifunctional non-structural protein in viral replication, virulence and host-specific genetic features ([@B59]; [@B56]; [@B5]; [@B6]; [@B55]). For the role of FMDV 3A in the antiviral immune response, when 3A gene was over-expressed in the PK-15 cell line (swine) and the HEK293 cell line (human), 3A protein can disrupt the transcriptional levels involved in RIG-I, MDA5, and MAVS and block the interaction between RIG-I/MDA5 and MAVS via its N-terminal region ([@B51]). Although some studies involved in the structural and non-structural proteins of FMDV have noted that these viral proteins take part in immune evasion by disrupting various nodes along signaling transduction mediated by IFNs, the over-expressed individual protein with *in vitro* physical structure and biological function may not reflect the real situation in infected cells by FMDV.

Conclusion
==========

Based on recent knowledge on IFNs, it is now well established that these cytokines function in the innate immune response against viral infection. Collectively, even though a series of recent reports strongly indicate that the host has evolved a complex network related to signal transduction induced by IFN against FMDV infection and FMDV relies on its viral proteins to suppress or ruin antiviral immune responses induced by IFN systems, the detailed and precise regulatory mechanisms need to be elucidated. This field is thus at a stage where there is an urgent need for the better understanding of both the basic biology and therapeutic antiviral activity of IFNs, and for deep investigations of how those proteins, without protease activities, derived from FMDV infection can influence and control the IFN signaling transduction *in vivo*.
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